HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

GSK180

inhibits kynurenine–3–monooxygenase; structure in first source

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzoxazoles: 68
      - GSK180: 1
Organic Chemicals: 133
- Carboxylic Acids: 973
  - Acyclic Acids
    - Propionates: 988
      - GSK180: 1
Lipids: 114793
- Fatty Acids: 27405
  - Volatile Fatty Acids: 3052
    - Propionates: 988
      - GSK180: 1

Experts

1.	Ancellin, Nicolas: 1 article (02/2016)
2.	Baily, James E: 1 article (02/2016)
3.	Beaufils, Benjamin: 1 article (02/2016)
4.	Binnie, Margaret: 1 article (02/2016)
5.	Bénéton, Véronique: 1 article (02/2016)
6.	Garden, O James: 1 article (02/2016)
7.	Haslam, Carl: 1 article (02/2016)
8.	Holmes, Duncan S: 1 article (02/2016)
9.	Homer, Natalie Z M: 1 article (02/2016)
10.	Howie, Sarah E M: 1 article (02/2016)

Related Diseases

1.	Multiple Organ Failure (MODS) 02/01/2016 - "Treatment with GSK180 resulted in rapid changes in the levels of kynurenine pathway metabolites in vivo, and it afforded therapeutic protection against MODS in a rat model of AP. "

Related Drugs and Biologics

1.	Kynurenine